|
[1]
|
Histological Manifestations of Diabetic Kidney Disease and its Relationship
with Insulin Resistance
Current Diabetes Reviews,
2023
DOI:10.2174/1573399818666220328145046
|
|
|
|
|
[2]
|
A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model
and clinical Manifestations: A Review
Current Diabetes Reviews,
2023
DOI:10.2174/1573399818666220426091238
|
|
|
|
|
[3]
|
NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes
Alexandria Journal of Medicine,
2023
DOI:10.1080/20905068.2023.2230051
|
|
|
|
|
[4]
|
Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
Frontiers in Endocrinology,
2022
DOI:10.3389/fendo.2022.871272
|
|
|
|
|
[5]
|
Insulin Resistance is Associated with Clinical Manifestations of Diabetic
Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney
Function Decline)
Current Diabetes Reviews,
2022
DOI:10.2174/1573399818666211117122604
|
|
|
|
|
[6]
|
Insulin Resistance is Associated with Clinical Manifestations of Diabetic
Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney
Function Decline)
Current Diabetes Reviews,
2022
DOI:10.2174/1573399818666211117122604
|
|
|
|
|
[7]
|
Insulin Resistance is Associated with Clinical Manifestations of Diabetic
Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney
Function Decline)
Current Diabetes Reviews,
2022
DOI:10.2174/1573399818666211117122604
|
|
|
|
|
[8]
|
Diabetic Kidney Disease
2021
DOI:10.1007/978-981-15-9301-7_4
|
|
|
|
|
[9]
|
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Diabetes, Obesity and Metabolism,
2020
DOI:10.1111/dom.14007
|
|
|
|
|
[10]
|
Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease
Frontiers in Physiology,
2020
DOI:10.3389/fphys.2020.578799
|
|
|
|
|
[11]
|
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Diabetes, Obesity and Metabolism,
2020
DOI:10.1111/dom.14007
|
|
|
|
|
[12]
|
Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score–Matched Analysis of a Nationwide, Biopsy-Based Cohort Study
Diabetes Care,
2019
DOI:10.2337/dc18-1320
|
|
|
|
|
[13]
|
Evolving spectrum of diabetic nephropathy
World Journal of Diabetes,
2019
DOI:10.4239/wjd.v10.i5.269
|
|
|
|
|
[14]
|
Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients
Journal of Medical Biochemistry,
2019
DOI:10.2478/jomb-2019-0037
|
|
|
|
|
[15]
|
Urinary Markers of Tubular Injury in Early Diabetic Nephropathy
International Journal of Nephrology,
2016
DOI:10.1155/2016/4647685
|
|
|
|
|
[16]
|
Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Nefrología,
2016
DOI:10.1016/j.nefro.2016.03.025
|
|
|
|
|
[17]
|
Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Nefrología (English Edition),
2016
DOI:10.1016/j.nefroe.2016.09.003
|
|
|
|
|
[18]
|
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
The Lancet Diabetes & Endocrinology,
2015
DOI:10.1016/S2213-8587(15)00094-7
|
|
|
|
|
[19]
|
Comparison of the Rate of Renal Function Decline in NonProteinuric Patients With and Without Diabetes
The American Journal of the Medical Sciences,
2015
DOI:10.1097/MAJ.0000000000000583
|
|
|
|
|
[20]
|
Unmasking of proteinuria in the course of genetic dissection of nonproteinuric diabetic nephropathy
Physiological Genomics,
2014
DOI:10.1152/physiolgenomics.00133.2013
|
|
|
|
|
[21]
|
Non-Proteinuric Diabetic Nephropathy
Current Diabetes Reports,
2014
DOI:10.1007/s11892-014-0529-6
|
|
|
|